Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease

Klaus Fellermann,M. Steffen,Jürgen Stein,A. Raedler,J. Hämling,Diether Ludwig,K. Loeschke,Stange Ef
DOI: https://doi.org/10.1046/j.1365-2036.2000.00695.x
2000-02-01
Abstract:Mycophenolate mofetil (MMF) is a new immunosuppressant with pharmacodynamic properties comparable to azathioprine. Recent reports found MMF to be effective in inflammatory bowel disease (IBD).
What problem does this paper attempt to address?